Endo, Inc. issued a voluntary recall for Clonazepam tablets “due to potential product carton strength mislabeling.” In the Food and Drug Administration’s (FDA) recall alert posted on Nov.
The original recall of Clonazepam Orally Disintegrating tablets was issued in July. The company is worried mislabeling could lead to unintentionally taking higher doses, increasing the risk of ...